Literature DB >> 18581409

Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.

Mark G Swanson1, Kayvan R Keshari, Z Laura Tabatabai, Jeffry P Simko, Katsuto Shinohara, Peter R Carroll, Andrew S Zektzer, John Kurhanewicz.   

Abstract

A fast and quantitative 2D high-resolution magic angle spinning (HR-MAS) total correlation spectroscopy (TOCSY) experiment was developed to resolve and quantify the choline- and ethanolamine-containing metabolites in human prostate tissues in approximately 1 hr prior to pathologic analysis. At a 40-ms mixing time, magnetization transfer efficiency constants were empirically determined in solution and used to calculate metabolite concentrations in tissue. Phosphocholine (PC) was observed in 11/15 (73%) cancer tissues but only 6/32 (19%) benign tissues. PC was significantly higher (0.39 +/- 0.40 mmol/kg vs. 0.02 +/- 0.07 mmol/kg, z = 3.5), while ethanolamine (Eth) was significantly lower in cancer versus benign prostate tissues (1.0 +/- 0.8 mmol/kg vs. 2.3 +/- 1.9 mmol/kg, z = 3.3). Glycerophosphocholine (GPC) (0.57 +/- 0.87 mmol/kg vs. 0.29 +/- 0.26 mmol/kg, z = 1.2), phosphoethanolamine (PE) (4.4 +/- 2.2 mmol/kg vs. 3.4 +/- 2.6 mmol/kg, z = 1.4), and glycerophosphoethanolamine (GPE) (0.54 +/- 0.82 mmol/kg vs. 0.15 +/- 0.15 mmol/kg, z = 1.8) were higher in cancer versus benign prostate tissues. The ratios of PC/GPC (3.5 +/- 4.5 vs. 0.32 +/- 1.4, z = 2.6), PC/PE (0.08 +/- 0.08 vs. 0.01 +/- 0.03, z = 3.5), PE/Eth (16 +/- 22 vs. 2.2 +/- 2.0, z = 2.4), and GPE/Eth (0.41 +/- 0.51 vs. 0.06 +/- 0.06, z = 2.6) were also significantly higher in cancer versus benign tissues. All samples were pathologically interpretable following HR-MAS analysis; however, degradation experiments showed that PC, GPC, PE, and GPE decreased 7.7 +/- 2.2%, while Cho+mI and Eth increased 18% in 1 hr at 1 degrees C and a 2250 Hz spin rate. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581409      PMCID: PMC2643975          DOI: 10.1002/mrm.21647

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  33 in total

Review 1.  Magnetic resonance imaging and spectroscopic imaging of prostate cancer.

Authors:  M G Swanson; D B Vigneron; T K Tran; J Kurhanewicz
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

2.  Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses.

Authors:  Andrew S Zektzer; Mark G Swanson; Samson Jarso; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2005-01       Impact factor: 4.668

3.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

Authors:  E O Aboagye; Z M Bhujwalla
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.

Authors:  Mark G Swanson; Andrew S Zektzer; Z Laura Tabatabai; Jeffry Simko; Samson Jarso; Kayvan R Keshari; Lars Schmitt; Peter R Carroll; Katsuto Shinohara; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

Review 5.  In vivo magnetic resonance spectroscopy in cancer.

Authors:  Robert J Gillies; David L Morse
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

6.  Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy.

Authors:  Iola F Duarte; Elizabeth G Stanley; Elaine Holmes; John C Lindon; Ana M Gil; Huiru Tang; Roxanne Ferdinand; Claire Gavaghan McKee; Jeremy K Nicholson; Hector Vilca-Melendez; Nigel Heaton; Gerard M Murphy
Journal:  Anal Chem       Date:  2005-09-01       Impact factor: 6.986

7.  Proton-decoupled 31P MRS in untreated pediatric brain tumors.

Authors:  Mark J Albers; Mark D Krieger; Ignacio Gonzalez-Gomez; Floyd H Gilles; J Gordon McComb; Marvin D Nelson; Stefan Blüml
Journal:  Magn Reson Med       Date:  2005-01       Impact factor: 4.668

8.  Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.

Authors:  Kristine Glunde; Chunfa Jie; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

9.  Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations.

Authors:  Daniel Morvan; Aicha Demidem; Janine Papon; Jean Claude Madelmont
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

10.  Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS.

Authors:  J M Macdonald; J Kurhanewicz; R Dahiya; M T Espanol; L H Chang; B Goldberg; T L James; P Narayan
Journal:  Magn Reson Med       Date:  1993-02       Impact factor: 4.668

View more
  49 in total

Review 1.  Application of metabolomics to prostate cancer.

Authors:  Bruce J Trock
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

Review 2.  Magnetic resonance spectroscopy: a promising tool for the diagnostics of human prostate cancer?

Authors:  Johannes Kurth; Elita Defeo; Leo L Cheng
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

3.  Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.

Authors:  Maria D Cao; Mailin Döpkens; Balaji Krishnamachary; Farhad Vesuna; Mayur M Gadiya; Per E Lønning; Zaver M Bhujwalla; Ingrid S Gribbestad; Kristine Glunde
Journal:  NMR Biomed       Date:  2012-01-26       Impact factor: 4.044

Review 4.  Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.

Authors:  Ananthakrishnan Sivaraman; Kulthe Ramesh Seetharam Bhat
Journal:  Indian J Surg Oncol       Date:  2017-01-23

Review 5.  NMR-based metabolomics studies of human prostate cancer tissue.

Authors:  Ana Rita Lima; Joana Pinto; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolomics       Date:  2018-06-18       Impact factor: 4.290

6.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

7.  (1)H- (31)P soft-HSQC pulse sequence specifically for detecting phosphomono- and diesters in biological samples.

Authors:  Xi-an Mao; Bin Jiang; Ling Jiang; Maili Liu
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

Review 8.  Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.

Authors:  Eva-Margarete Spur; Emily A Decelle; Leo L Cheng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-03       Impact factor: 9.236

Review 9.  High-resolution magic angle spinning 1H MRS in prostate cancer.

Authors:  Emily A Decelle; Leo L Cheng
Journal:  NMR Biomed       Date:  2013-03-26       Impact factor: 4.044

10.  NMR method for measuring carbon-13 isotopic enrichment of metabolites in complex solutions.

Authors:  Ian A Lewis; Ryan H Karsten; Mark E Norton; Marco Tonelli; William M Westler; John L Markley
Journal:  Anal Chem       Date:  2010-06-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.